Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Matteo C. Da Vià"'
Autor:
Matteo C. Da Vià, Bachisio Ziccheddu, Akihiro Maeda, Filippo Bagnoli, Giulia Perrone, Niccolò Bolli
Publikováno v:
HemaSphere, Vol 4, Iss 6, p e502 (2020)
Abstract. The knowledge of cancer origin and the subsequent tracking of disease evolution represent unmet needs that will soon be within clinical reach. This will provide the opportunity to improve patient's stratification and to personalize treatmen
Externí odkaz:
https://doaj.org/article/17a6dd0a5aed464b87896560ed433e31
Autor:
Antonio G. Solimando, Matteo C. Da Vià, Patrizia Leone, Paola Borrelli, Giorgio A. Croci, Paula Tabares, Andreas Brandl, Giuseppe Di Lernia, Francesco P. Bianchi, Silvio Tafuri, Torsten Steinbrunn, Alessandra Balduini, Assunta Melaccio, Simona De Summa, Antonella Argentiero, Hilka Rauert-Wunderlich, Maria A. Frassanito, Paolo Ditonno, Erik Henke, Wolfram Klapper, Roberto Ria, Carolina Terragna, Leo Rasche, Andreas Rosenwald, K. Martin Kortüm, Michele Cavo, Domenico Ribatti, Vito Racanelli, Hermann Einsele, Angelo Vacca, Andreas Beilhack
Publikováno v:
Haematologica, Vol 106, Iss 7 (2020)
Interactions of malignant multiple myeloma (MM) plasma cells (MM-cells) with the microenvironment control MM-cell growth, survival, drug-resistance and dissemination. As in MM microvascular density increases in the bone marrow (BM), we investigated w
Externí odkaz:
https://doaj.org/article/c2545760d0c3467b8997b010e53370db
Autor:
Ilaria Ambaglio, Luca Malcovati, Elli Papaemmanuil, Coby M. Laarakkers, Matteo G. Della Porta, Anna Gallì, Matteo C. Da Vià, Elisa Bono, Marta Ubezio, Erica Travaglino, Riccardo Albertini, Peter J. Campbell, Dorine W. Swinkels, Mario Cazzola
Publikováno v:
Haematologica, Vol 98, Iss 3 (2013)
Somatic mutations of the RNA splicing machinery have been recently identified in myelodysplastic syndromes. In particular, a strong association has been found between SF3B1 mutation and refractory anemia with ring sider-oblasts, a condition character
Externí odkaz:
https://doaj.org/article/060595973faf4ecaaade8d4cb70e9372
Autor:
Kenneth C. Anderson, Irene M. Ghobrial, Ruben D. Carrasco, Tomasz Sewastianik, Niccolo' Bolli, Matteo C. Da Vià, Gulden Camci-Unal, Xinchen Wu, Maria Moscvin, Yu-Tzu Tai, Kenneth Wen, Tianzeng Chen, Anil Aktas Samur, Annamaria Gullà, Yawara Kawano, Antonio Sacco, Aldo M. Roccaro, Matthew Ho, Peter G. Czarnecki, Giada Bianchi
The bone marrow (BM) microenvironment actively promotes multiple myeloma pathogenesis, and therapies targeting both cancer cells and the niche are highly effective. We were interested in identifying novel signaling pathways supporting multiple myelom
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3b02d611346ad1eefa00094115a447f1
https://doi.org/10.1158/2643-3230.c.6550300
https://doi.org/10.1158/2643-3230.c.6550300
Autor:
Kenneth C. Anderson, Irene M. Ghobrial, Ruben D. Carrasco, Tomasz Sewastianik, Niccolo' Bolli, Matteo C. Da Vià, Gulden Camci-Unal, Xinchen Wu, Maria Moscvin, Yu-Tzu Tai, Kenneth Wen, Tianzeng Chen, Anil Aktas Samur, Annamaria Gullà, Yawara Kawano, Antonio Sacco, Aldo M. Roccaro, Matthew Ho, Peter G. Czarnecki, Giada Bianchi
Supplementary Figure 1 showing ROBO1 expression in primary MM cells versus normal donor bone marrow plasma cells via gene expression profiling and immunohistochemistry. Supplementary Figure 2 showing distribution of ROBO1 expression in the CoMMpass d
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::61bd46dd01d9ed92d4805d36ff6c55a9
https://doi.org/10.1158/2643-3230.22543528.v1
https://doi.org/10.1158/2643-3230.22543528.v1
Autor:
Kenneth C. Anderson, Irene M. Ghobrial, Ruben D. Carrasco, Tomasz Sewastianik, Niccolo' Bolli, Matteo C. Da Vià, Gulden Camci-Unal, Xinchen Wu, Maria Moscvin, Yu-Tzu Tai, Kenneth Wen, Tianzeng Chen, Anil Aktas Samur, Annamaria Gullà, Yawara Kawano, Antonio Sacco, Aldo M. Roccaro, Matthew Ho, Peter G. Czarnecki, Giada Bianchi
Supplementary Methods
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2bbb3f295f13f96f02efe3daa94cfa0a
https://doi.org/10.1158/2643-3230.22543525
https://doi.org/10.1158/2643-3230.22543525
Autor:
Antonio Matera, Alessio Marella, Akihiro Maeda, Matteo C. Da Vià, Francesca Lazzaroni, Sonia Fabris, Stefania Pioggia, Laura Porretti, Federico Colombo, Federica Torricelli, Antonino Neri, Elisa Taiana, Giuseppina Fabbiano, Valentina Traini, Elisa Genuardi, Daniela Drandi, Niccolò Bolli, Marta Lionetti
Publikováno v:
International Journal of Molecular Sciences; Volume 23; Issue 24; Pages: 15691
Multiple myeloma (MM) has a highly heterogeneous genetic background, which complicates its molecular tracking over time. Nevertheless, each MM patient’s malignant plasma cells (PCs) share unique V(D)J rearranged sequences at immunoglobulin loci, wh
Autor:
Hermann Einsele, Antoine-Emmanuel Saliba, Leo Rasche, Michael Hudecek, Kristen Hege, Anke Heidemeier, Shari Kaiser, Niels Weinhold, Johannes Duell, Sophia Danhof, Max S. Topp, Xiang Zhou, Oliver Dietrich, Matteo C. Da Vià, Claudia Haferlach, Sabrina Prommersberger, Manja Meggendorfer, Andreas Rosenwald, Maria-Elisabeth Goebeler, Marietta Truger, Sven Twardziok, K. Martin Kortüm, Florian Erhard, Panagiota Arampatzi, Manik Chatterjee, Viktoria Fuhr, Sabrina Kraus
Publikováno v:
Nature medicine. 27(4)
B cell maturation antigen (BCMA) is a target for various immunotherapies and a biomarker for tumor load in multiple myeloma (MM). We report a case of irreversible BCMA loss in a patient with MM who was enrolled in the KarMMa trial ( NCT03361748 ) and